Shareholders' Equity

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Shareholders' Equity

(11) Shareholders’ Equity

The components of accumulated other comprehensive loss, net of tax, were as follows:

	September 30,			December 31,
	2023			2022
Foreign currency translation	$	(362.5	)	$	(369.7	)
Translation loss on long-term intercompany loans, net of income taxes of $19.1 on both dates		(133.4	)		(132.8	)
Gain on derivative instruments, net of income tax benefit of $(4.8) and $(5.3), respectively		25.5			53.4
Gain on interest rate swap, net of income taxes of $0.4 on both dates		1.1			1.4
Defined benefit pension plans, net of income tax benefit of $(20.1) and $(20.4), respectively		(14.5	)		(12.2	)
Retiree health care plan, net of income taxes of $1.8 and $1.9, respectively		0.7			1.2
Accumulated other comprehensive loss	$	(483.1	)	$	(458.7	)

Noncontrolling interests, reported in total shareholders' equity in our Consolidated Balance Sheets, represent amounts related to majority-owned subsidiaries in which we have a controlling financial interest. Net earnings attributable to these noncontrolling interests are recorded in interest and other expenses, net in our Consolidated Statements of Operations. During the three months ended September 30, 2023 and 2022, we recorded an expense of $0.1 and a benefit of $0.1, respectively, and expenses of $0.2 and $0.6 for the nine months ended September 30, 2023 and 2022, respectively.

The Board of Directors declared a semi-annual dividend of $1.47 and $1.36 per share on May 5, 2023 and May 6, 2022, respectively. The 2023 dividends were paid on June 15, 2023 to shareholders of record as of June 1, 2023. The 2022 dividends were paid on June 15, 2022 to shareholders of record as of June 1, 2022.

In August 2023, the Board of Directors authorized the repurchase of 5.0 million shares of our common stock, with terms consistent with the previous authorizations. This authorization was in addition to the August 2021 and 2019 Board authorizations to repurchase 4.0 million and 6.0 million shares of our common stock, respectively. Share repurchases may be made from time to time through a variety of methods, including open market purchases, block transactions, privately negotiated transactions or similar facilities. During the nine months ended September 30, 2023, we repurchased a total of 1.7 million shares under the 2021 authorization at a cost of $129.8. During the nine months ended September 30, 2022, we repurchased a total of 2.8 million shares comprised of 1.2 million shares under the 2019 authorization and 1.6 million shares under the 2021 authorization, at a total cost of $245.0. As of September 30, 2023, there were 5.0 million and 0.3 million shares remaining authorized for repurchase under the 2023 authorization and 2021 authorization, respectively, and no shares remaining authorized for repurchase under the 2019 authorization.